2020

  1. ICD-10-CM Codes
    2. ›
  2. C00-D49 Neoplasms
    3. ›
  3. C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
    4. ›
  4. C96- Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
    5. ›
  5. 2020 ICD-10-CM Diagnosis Code C96

2020 ICD-10-CM Diagnosis Code C96

Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

    2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
  • C96 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • Short description: Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss
  • The 2020 edition of ICD-10-CM C96 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of C96 - other international versions of ICD-10 C96 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C96. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (
    ICD-10-CM Diagnosis Code Z85.79

    Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues

      2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
    Applicable To
    Type 1 Excludes
    • multiple myeloma in remission (C90.01)
    • plasma cell leukemia in remission (C90.11)
    • plasmacytoma in remission (C90.21)
    Z85.79
    )
The following code(s) above C96 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C96:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2020 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to C96:
  • Type 1 Excludes: C77
    ICD-10-CM Diagnosis Code C77

    Secondary and unspecified malignant neoplasm of lymph nodes

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
    • mesentary metastasis of carcinoid tumor (C7B.04)
    • secondary carcinoid tumors of distant lymph nodes (C7B.01)
  • Applicable To: Z80.7
    , Z85.79
    ICD-10-CM Diagnosis Code Z80.7

    Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues

      2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
    Applicable To
    ICD-10-CM Diagnosis Code Z85.79

    Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues

      2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
    Applicable To
    Type 1 Excludes
    • multiple myeloma in remission (C90.01)
    • plasma cell leukemia in remission (C90.11)
    • plasmacytoma in remission (C90.21)
ICD-10-CM Codes Adjacent To C96
C95.01 …… in remission
C95.02 …… in relapse
C95.1 Chronic leukemia of unspecified cell type
C95.10 …… not having achieved remission
C95.11 …… in remission
C95.12 …… in relapse
C95.9 Leukemia, unspecified
C95.90 …… not having achieved remission
C95.91 …… in remission
C95.92 …… in relapse
C96 Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
C96.2 Malignant mast cell neoplasm
C96.20 …… unspecified
C96.21 Aggressive systemic mastocytosis
C96.22 Mast cell sarcoma
C96.29 Other malignant mast cell neoplasm
C96.4 Sarcoma of dendritic cells (accessory cells)
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
C96.6 Unifocal Langerhans-cell histiocytosis
C96.A Histiocytic sarcoma

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com